Lack of miR-216b-5p, miR-33a-5p or miR-122-5p in MSCs exosomes promotes breast cancer glycolysis by targeting HK2, LDHA and PKM2

Jiyi Xia; Xiaolan Yu; Xiguang Mao; Hongyuan An; Xiaoping Tang; Xiaoyan Wang; Tao He; Yong Liu

doi:10.18632/oncotarget.22897

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 01/02/2018.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Research Papers:

Lack of miR-216b-5p, miR-33a-5p or miR-122-5p in MSCs exosomes promotes breast cancer glycolysis by targeting HK2, LDHA and PKM2

Jiyi Xia, Xiaolan Yu, Xiguang Mao, Hongyuan An, Xiaoping Tang, Xiaoyan Wang, Tao He _ and Yong Liu

Jiyi Xia1,*, Xiaolan Yu2,*, Xiguang Mao3, Hongyuan An4, Xiaoping Tang5, Xiaoyan Wang5, Tao He1 and Yong Liu6

1Cancer Research Institute of SouthWest Medical University, Luzhou, Sichuan, China

2Department of Obstetrics and Gynecology, Affiliated TCM Hospital of SouthWest Medical University, Luzhou, Sichuan, China

3Department of Obstetrics and Gynecology, Affiliated Hospital of SouthWest Medical University, Luzhou, Sichuan, China

4The Second Ward of Surgery (Breast Surgery), Luzhou People’s Hospital, Luzhou, Sichuan, China

5Experimental Medicine Center, The Affiliated Hospital of SouthWest Medical University, Luzhou, Sichuan, China

6Department of Pathology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China

*These authors have contributed equally to this work

Correspondence to:

Tao He, email: [email protected]

Yong Liu, email: [email protected]

Keywords: MSC; exosomes; breast cancer; miRNA

Received: April 27, 2017 Accepted: October 28, 2017 Epub: January 02, 2018

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 22897

Publication Alerts

Withdrawal Notice

Research Papers:

Lack of miR-216b-5p, miR-33a-5p or miR-122-5p in MSCs exosomes promotes breast cancer glycolysis by targeting HK2, LDHA and PKM2